Martingale Asset Management trimmed its stake in Regeneron Pharmaceuticals by 6.9% last quarter, selling off 1,503 shares.

A federal judge tossed a lawsuit accusing Bristol Myers of monopolizing the blood cancer drug Pomalyst using shady patent ...

NPPA revises ceiling price of diagnostic agent following DoP's review order: Gireesh Babu, New Delhi Monday, April 14, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing Au ...